Metabolic study for fatty liver disease in bariatric surgery patients
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how the body processes energy in people with fatty liver disease who are having weight-loss surgery. It may help doctors understand the disease better and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for bariatric (weight-loss) surgery at Vanderbilt University Medical Center.
- Your body mass index (BMI) is 40 or higher, or over 35 with a related health condition like diabetes, high blood pressure, or sleep apnea.
- You can have an MRI and MRE (special scans of your liver) and are willing to have extra blood draws and a small tissue sample taken during your surgery.
- You are able to understand and sign the consent form in English.
- You do not have a pacemaker, defibrillator, or other metal implant that is not safe for MRI.
- You have not had prior stomach, intestinal, or pancreatic surgery that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if weight loss surgery can improve liver fibrosis (scarring) in people with obesity and advanced liver disease. It may help those considering surgery to know if their liver health can get better.
This study looks at how the body’s insulin-sensitivity (how well your body uses sugar/insulin) and organ function change after certain medical procedures. It may help researchers understand why some people improve after surgery or liver transplant and guide future care.
This study looks at how weight loss affects the energy-producing parts of your cells (mitochondria). It may help researchers understand how bariatric surgery improves overall health.
This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.
This study looks at a possible link between MASH (liver inflammation with fat buildup) and tiny cell structures that help liver cells work. Researchers want to understand this better in people having weight-loss surgery, where a small liver sample will be taken.
This study collects small tissue samples during planned weight-loss surgery to better understand metabolism and how insulin works in people with and without type 2 diabetes. You may help researchers by allowing their team to take these samples while you are already having surgery.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.